T10Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): a negligible risk?
Gambino, A; Cabras, M; Fusco, V; Bertetto, O; De Martino, I; Alessio, M; Numico, G
- 期刊名称Annals of Oncology
- 作者Gambino, A; Cabras, M; Fusco, V; Bertetto, O; De Martino, I; Alessio, M; Numico, G
- 卷第28卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小54.16KB
- 发表时间2017-10-01
- DOI10.1093/annonc/mdx436.009